Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder
Status:
Withdrawn
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety of multiple doses of NSA-789 in subjects with
schizophrenia or schizoaffective disorder. This study will also assess how NSA-789 is
absorbed and eliminated, and its effect, if any, on the brain.